Lymphoblastic Leukemia

• CLINICAL_TRIALS trial_result · 2026-04-24
  Clinical Trial Update: A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia [Phase 3]

  Phase 3 trial evaluating blinatumomab in combination with chemotherapy for newly diagnosed B lymphoblastic leukemia; the study is currently …

• CLINICAL_TRIALS research · 2025-01-13
  Clinical Trial Update: A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL) [Phase 1, Phase 2]

  This update describes BEAM-201, a study in relapsed/refractory T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma, in Pha…

• CLINICAL_TRIALS trial_result · 2023-03-09
  Clinical Trial Update: Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia [Phase 1, Phase 2]

  Clinical trial update for CART2219.1, a dual anti-CD22/CD19 CAR-T therapy, in relapsed/refractory B-lineage leukemia, spanning Phase 1 and P…

• CLINICAL_TRIALS trial_result · 2021-06-14
  Clinical Trial Update: Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies [NA]

  A completed clinical trial evaluating intensity modulated total marrow irradiation (IM-TMI) for advanced hematologic malignancies, with resu…

• CLINICAL_TRIALS trial_result · 2021-01-12
  Clinical Trial Update: Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor [Phase 2, Phase 3]

  Clinical trial update on ATIR donor lymphocyte preparation for haploidentical stem cell transplantation; study terminated with posted result…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2017-05-22
  Clinical Trial Update: Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma [Phase 2]

  Phase 2 trial evaluating rituximab in patients undergoing donor peripheral blood stem cell transplantation for relapsed or refractory B-cell…